Akero Therapeutics, Inc.
AKRODelisted Dec 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001744659
Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Akero Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- −5 vs. Q3 2021
- Shares held
- 35.3M
- +7.33M (+26.2%) vs. Q3 2021
- Total value
- $746.8M
- +$120.8M (+19.3%) vs. Q3 2021
- New holders
- 11
- 30 more added
- Sold out
- 16
- 33 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 5 | $533.0K |
| Q3 2025 | 265 | $4.34B |
| Q2 2025 | 257 | $4.92B |
| Q1 2025 | 240 | $3.50B |
| Q4 2024 | 191 | $2.06B |
| Q3 2024 | 168 | $2.09B |
| Q2 2024 | 153 | $1.68B |
| Q1 2024 | 173 | $1.85B |
| Q4 2023 | 157 | $1.38B |
| Q3 2023 | 181 | $2.90B |
| Q2 2023 | 157 | $2.63B |
| Q1 2023 | 156 | $1.84B |
| Q4 2022 | 162 | $2.66B |
| Q3 2022 | 146 | $1.59B |
| Q2 2022 | 113 | $329.6M |
| Q1 2022 | 103 | $499.2M |
| Q4 2021 | 97 | $746.8M |
| Q3 2021 | 103 | $626.0M |
| Q2 2021 | 97 | $684.2M |
| Q1 2021 | 109 | $913.6M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Akero Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Stansberry Asset Management, LLC | 0 | $0 | 0.00% | −21,883−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −16,330−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −11,642−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −9,254−100.0% | Sold out |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −3,470−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −650−100.0% | Sold out |
| Evolution Wealth Advisors, LLC | 0 | $0 | 0.00% | −211−100.0% | Sold out |
| Brewin Dolphin Ltd | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Johnson Midwest Financial, LLC | 0 | $0 | 0.00% | −103−100.0% | Sold out |
| Toth Financial Advisory Corp | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| First Mercantile Trust Co | – | – | – | – | Not filed |